Clinical Trial Update: Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and treatment satisfaction after switching adults with chronic immune thrombocytopenia to avatrombopag from eltrombopag or romiplo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DOPTELET (avatrombopag)
• Nplate (romiplostim)
• Promacta (eltrombopag)

Snippet

Sponsor: Sobi, Inc. | Conditions: Immune Thrombocytopenia | Phase 4 | Status: COMPLETED | Results posted: 2025-01-16